MKL Markel (MKL) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0001096343
Congress · 1
Funds added, last quarter
433
13F, latest reported quarter
What the filings say about MKL
Insiders, 180 days
+$230.7K net bought
2 buyers · 1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 2 sold
Latest: sale, 2026-08-25
Markel insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MARKEL GROUP INC. insiders bought a net $230.7K of stock across 271 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 10 earlier Form 4 trades (code P or S) here by this insider (2 buys, 8 sales), the last on May 23, 2025.
- The trade is 4.2% of the 645 shares held after it.
- No other insider sold within 30 days.
- 433 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Harris Greta J sold about $49.9K of MKL on May 22, 2026; 433 funds added in the latest 13F quarter.Context
- 10 earlier Form 4 trades (code P or S) here by this insider (2 buys, 8 sales), the last on May 23, 2025.
- The trade is 5.1% of the 686 shares held after it.
- No other insider sold within 30 days.
- 433 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Harris Greta J sold about $64.6K of MKL on May 22, 2026; 433 funds added in the latest 13F quarter.Context
- 10 earlier Form 4 trades (code P or S) here by this insider (2 buys, 8 sales), the last on May 23, 2025.
- The trade is 2.1% of the 672 shares held after it.
- No other insider sold within 30 days.
- 433 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Harris Greta J sold about $25.9K of MKL on May 22, 2026; 433 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on May 6, 2026.
- +3.8% median (+3.8% mean) 90-day return after 2 previous buys.
- The trade is 9.1% of the 550 shares held after it.
- 1 other insider bought within 30 days.
- 433 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Leopold Diane bought about $89.5K of MKL on May 7, 2026; 1 other insider bought within 30 days and 433 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Feb 16, 2023.
- The trade is 4.6% of the 2,190 shares held after it.
- 1 other insider bought within 30 days.
- 433 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Leopold Diane bought about $179.3K of MKL on May 6, 2026, the largest insider purchase at the company since 2025; 1 other insider bought within 30 days and 433 funds added in the latest 13F quarter.271 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$230.7K over 180 days
more than 85% of Insurance
Congress
1 member bought in the last year
the lowest in Insurance
Funds
433 funds bought in last quarter
more than 82% of Insurance
Revenue
+4.7% year over year
below 66% of Insurance
Margin
13.6% net margin
more than 59% of Insurance
Buybacks
$370.7M repurchased, FY to 2026-06-30
more than 69% of Insurance
Short interest
2.3% of the float short (float per yahoo 2026-10-26) · 3.5 days to cover · settled 2026-09-30
below 65% of Insurance
What changed in the last 30 days
Oct 27Insider selling stopped: no sales in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Oct 27Insider buying stopped: no purchases in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch MKL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-0.9%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MKL: institutional holders (13F)
13F holdings, latest reported quarter
697,836 sh
$1.4B
545,650 sh
$1.1B
521,976 sh
$1.0B
406,759 sh
$794.4M
350,660 sh
$684.8M
Congress trades in MKL
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-08-25 · disclosed 15 days later
$100,001 - $250,000
Sold 2026-07-29 · disclosed 5 days later
$1,001 - $15,000
Sold 2026-07-28 · disclosed 6 days later
$1,001 - $15,000
Sold 2026-07-27 · disclosed 7 days later
$1,001 - $15,000
Sold 2026-07-24 · disclosed 10 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
MKL planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
MKL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Blue Chip Investor Fund
$3.4M position · as of 2026-06-30
7.4%
Hennessy Focus Fund
$27.9M position · as of 2026-07-31
6.1%
Davis Financial Fund
$69.2M position · as of 2026-06-30
6.0%
Clipper Fund
$87.3M position · as of 2026-06-30
5.9%
FAM VALUE FUND
$105.2M position · as of 2026-06-30
5.8%
Davis Select Financial ETF
$27.7M position · as of 2026-07-31
5.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Thomas S. Gayner
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$14.1M
$18.3M
$4.2M
+108%
+133%
2024
$9.7M
$11.9M
$3.1M
+67%
+113%
2023
$8.1M
$8.6M
$2.5M
+37%
+59%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $230.7K bought by insiders over 180 days, 433 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
MKL financials
Revenue growth
+4.7%
XBRL, annual
Net margin
13.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM MKL
| FY Dec 2025 | n/a |
| FY Dec 2024 | $16.6B |
| FY Dec 2023 | $15.8B |
| FY Dec 2022 | $11.7B |
| FY Dec 2021 | $12.8B |
| Jun 2026 | $4.0B |
| Mar 2026 | $3.6B |
| Dec 2025 | $4.0B |
| Sep 2025 | $3.9B |
| Jun 2025 | $4.6B |
| Mar 2025 | $3.5B |
| Dec 2024 | $3.8B |
| Sep 2024 | $4.6B |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM MKL
| FY Dec 2025 | n/a |
| FY Dec 2024 | +16.5% |
| FY Dec 2023 | +12.6% |
| FY Dec 2022 | -1.9% |
| FY Dec 2021 | +18.9% |
| Jun 2026 | +29.1% |
| Mar 2026 | -6.0% |
| Dec 2025 | +14.4% |
| Sep 2025 | +19.1% |
| Jun 2025 | +14.3% |
| Mar 2025 | +3.4% |
| Dec 2024 | +14.3% |
| Sep 2024 | +19.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.1B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MKL
| FY Dec 2025 | $2.6B |
| FY Dec 2024 | $2.3B |
| FY Dec 2023 | $2.5B |
| FY Dec 2022 | $2.5B |
| FY Dec 2021 | $2.1B |
| Jun 2026 | $384.5M |
| Mar 2026 | -$31.4M |
| Dec 2025 | $599.1M |
| Sep 2025 | $1.2B |
| Jun 2025 | $453.8M |
| Mar 2025 | $335.5M |
| Dec 2024 | $420.0M |
| Sep 2024 | $838.9M |
At each fiscal year end
Single quarter
Debt to equity
0.23x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity MKL
| FY Dec 2025 | 0.23x |
| FY Dec 2024 | 0.26x |
| FY Dec 2023 | 0.25x |
| FY Dec 2022 | 0.31x |
| FY Dec 2021 | 0.30x |
| Jun 2026 | 0.23x |
| Mar 2026 | 0.24x |
| Dec 2025 | 0.23x |
| Sep 2025 | 0.24x |
| Jun 2025 | 0.25x |
| Mar 2025 | 0.26x |
| Dec 2024 | 0.26x |
| Sep 2024 | 0.26x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.53x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt MKL
| FY Dec 2025 | 0.64x |
| FY Dec 2024 | 0.60x |
| FY Dec 2023 | 0.74x |
| FY Dec 2022 | 0.66x |
| FY Dec 2021 | 0.52x |
| Jun 2026 | 0.53x |
| Mar 2026 | 0.55x |
| Dec 2025 | 0.64x |
| Sep 2025 | 0.61x |
| Jun 2025 | 0.52x |
| Mar 2025 | 0.53x |
| Dec 2024 | 0.60x |
| Sep 2024 | 0.67x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MKL
| FY Dec 2025 | +11.9% |
| FY Dec 2024 | +17.2% |
| FY Dec 2023 | +14.2% |
| FY Dec 2022 | -1.6% |
| FY Dec 2021 | +17.6% |
| Jun 2026 | +12.6% |
| Mar 2026 | +10.1% |
| Dec 2025 | +11.9% |
| Sep 2025 | +11.9% |
| Jun 2025 | +13.5% |
| Mar 2025 | +11.2% |
| Dec 2024 | +17.2% |
| Sep 2024 | +19.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MKL
| FY Dec 2025 | +3.2% |
| FY Dec 2024 | +4.7% |
| FY Dec 2023 | +3.8% |
| FY Dec 2022 | -0.4% |
| FY Dec 2021 | +5.4% |
| Jun 2026 | +3.3% |
| Mar 2026 | +2.7% |
| Dec 2025 | +3.2% |
| Sep 2025 | +3.2% |
| Jun 2025 | +3.5% |
| Mar 2025 | +3.0% |
| Dec 2024 | +4.7% |
| Sep 2024 | +5.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.8%
operating income after a 21.4% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MKL
| FY Dec 2025 | +13.8% |
| FY Dec 2024 | +17.5% |
| FY Dec 2023 | +16.7% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | +18.1% |
| Jun 2026 | +12.8% |
| Mar 2026 | +11.5% |
| Dec 2025 | +13.8% |
| Sep 2025 | +13.1% |
| Jun 2025 | +15.2% |
| Mar 2025 | +12.3% |
| Dec 2024 | +17.5% |
| Sep 2024 | +21.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed MKL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.29x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MKL
| FY Dec 2025 | 12.67x |
| FY Dec 2024 | 8.67x |
| FY Dec 2023 | 9.67x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 7.00x |
| Jun 2026 | 10.75x |
| Mar 2026 | 13.81x |
| Dec 2025 | 12.67x |
| Sep 2025 | 11.95x |
| Jun 2025 | 11.97x |
| Mar 2025 | 13.76x |
| Dec 2024 | 8.67x |
| Sep 2024 | 7.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$24.1B
market value at close 2026-10-23 on 2026-07-22 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value MKL
| FY Dec 2025 | $27.4B |
| FY Dec 2024 | $22.8B |
| FY Dec 2023 | $18.8B |
| FY Dec 2022 | $17.7B |
| FY Dec 2021 | $17.2B |
| Jun 2026 | $25.4B |
| Mar 2026 | $24.8B |
| Dec 2025 | $27.4B |
| Sep 2025 | $24.4B |
| Jun 2025 | $26.0B |
| Mar 2025 | $24.1B |
| Dec 2024 | $22.8B |
| Sep 2024 | $20.8B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.1%
TTM free cash flow over market value at close 2026-10-23
FCF yield MKL
| FY Dec 2025 | +9.4% |
| FY Dec 2024 | +10.5% |
| FY Dec 2023 | +13.5% |
| FY Dec 2022 | +13.9% |
| FY Dec 2021 | +12.6% |
| Jun 2026 | +8.7% |
| Mar 2026 | +9.1% |
| Dec 2025 | +9.4% |
| Sep 2025 | +9.8% |
| Jun 2025 | +8.1% |
| Mar 2025 | +8.9% |
| Dec 2024 | +10.5% |
| Sep 2024 | +13.0% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.16x
P/E over trailing EPS growth of 9%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MKL
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.24x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.03x |
| Jun 2026 | 1.21x |
| Mar 2026 | 6.72x |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 1.37x |
| Mar 2025 | n/a |
| Dec 2024 | 0.24x |
| Sep 2024 | 0.13x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $15.5B | $16.6B | $15.8B | $11.7B |
| Operating income | $3.2B | $3.7B | $2.9B | -$93.3M |
| Net income | $2.1B | $2.7B | $2.0B | -$216.3M |
| EPS (diluted) | 169.22 | 199.32 | 146.98 | -23.72 |
| Operating cash flow | $2.8B | $2.6B | $2.8B | $2.7B |
| Cash | $4.0B | $3.7B | $3.7B | $4.1B |
| Long-term debt | $4.3B | $4.3B | $3.8B | $4.1B |
| Buybacks | $429.5M | $572.7M | $445.5M | $290.8M |
SEC XBRL, fiscal years, as known on 2026-10-27
MKL Stock Sonar score 6/7 axes
Find similar shapesCompareMKL ranks highest on insider conviction (86th percentile) and financial health (55th), and lowest on growth (34th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MKL filings, in plain words
Are Markel insiders buying or selling MKL?
In the 180 days to 2026-10-27, Markel insiders were net buyers, a net $230.7K: $371.1K of purchases and $140.4K of sales reported on Form 4, by 2 buyers and 1 seller.
Have members of Congress traded MKL?
Yes. In the year to 2026-10-27, 1 House member disclosed buying MKL and 2 House members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25.
Read the full summary
In the 180 days to 2026-10-27, Markel insiders were net buyers of MKL, a net $230.7K across purchases and sales reported on Form 4 by 2 buyers and 1 seller. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 1 member of Congress disclosed buying MKL and 2 members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
